120 related articles for article (PubMed ID: 26398480)
1. OCT4B1 promotes cell growth, migration and invasion suppressing sensitivity to οxaliplatin in colon cancer.
Wen KM; Zhang GH; Li J; Chen ZQ; Cheng YL; Su X; Zeng QL
Oncol Rep; 2015 Dec; 34(6):2943-52. PubMed ID: 26398480
[TBL] [Abstract][Full Text] [Related]
2. OCT4B1, a novel spliced variant of OCT4, is highly expressed in gastric cancer and acts as an antiapoptotic factor.
Asadi MH; Mowla SJ; Fathi F; Aleyasin A; Asadzadeh J; Atlasi Y
Int J Cancer; 2011 Jun; 128(11):2645-52. PubMed ID: 20824712
[TBL] [Abstract][Full Text] [Related]
3. Epithelial-mesenchymal transition and cancer stem cell-like phenotype induced by Twist1 contribute to acquired resistance to irinotecan in colon cancer.
Yang Y; Wang G; Zhu D; Huang Y; Luo Y; Su P; Chen X; Wang Q
Int J Oncol; 2017 Aug; 51(2):515-524. PubMed ID: 28627611
[TBL] [Abstract][Full Text] [Related]
4. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
Alberti L; Losi L; Leyvraz S; Benhattar J
PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
[TBL] [Abstract][Full Text] [Related]
5. FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells.
Choi EJ; Seo EJ; Kim DK; Lee SI; Kwon YW; Jang IH; Kim KH; Suh DS; Kim JH
Oncotarget; 2016 Jan; 7(3):3506-19. PubMed ID: 26654944
[TBL] [Abstract][Full Text] [Related]
6. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
[TBL] [Abstract][Full Text] [Related]
7. Positive correlation of Oct4 and ABCG2 to chemotherapeutic resistance in CD90(+)CD133(+) liver cancer stem cells.
Jia Q; Zhang X; Deng T; Gao J
Cell Reprogram; 2013 Apr; 15(2):143-50. PubMed ID: 23438193
[TBL] [Abstract][Full Text] [Related]
8. The novel OCT4 spliced variant OCT4B1 can generate three protein isoforms by alternative splicing into OCT4B.
Gao Y; Wang X; Han J; Xiao Z; Chen B; Su G; Dai J
J Genet Genomics; 2010 Jul; 37(7):461-5. PubMed ID: 20659710
[TBL] [Abstract][Full Text] [Related]
9. ABCG2-meditated multidrug resistance and tumor-initiating capacity of side population cells from colon cancer.
Xie ZY; Lv K; Xiong Y; Guo WH
Oncol Res Treat; 2014; 37(11):666-8, 670-2. PubMed ID: 25427584
[TBL] [Abstract][Full Text] [Related]
10. ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells.
Svirnovski AI; Shman TV; Serhiyenka TF; Savitski VP; Smolnikova VV; Fedasenka UU
Hematology; 2009 Aug; 14(4):204-12. PubMed ID: 19635183
[TBL] [Abstract][Full Text] [Related]
11. miR-219-5p plays a tumor suppressive role in colon cancer by targeting oncogene Sall4.
Cheng J; Deng R; Zhang P; Wu C; Wu K; Shi L; Liu X; Bai J; Deng M; Shuai X; Gao J; Wang G; Tao K
Oncol Rep; 2015 Oct; 34(4):1923-32. PubMed ID: 26238082
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Wnt signaling pathway decreases chemotherapy-resistant side-population colon cancer cells.
Chikazawa N; Tanaka H; Tasaka T; Nakamura M; Tanaka M; Onishi H; Katano M
Anticancer Res; 2010 Jun; 30(6):2041-8. PubMed ID: 20651349
[TBL] [Abstract][Full Text] [Related]
13. Vatalanib sensitizes ABCB1 and ABCG2-overexpressing multidrug resistant colon cancer cells to chemotherapy under hypoxia.
To KK; Poon DC; Wei Y; Wang F; Lin G; Fu LW
Biochem Pharmacol; 2015 Sep; 97(1):27-37. PubMed ID: 26206183
[TBL] [Abstract][Full Text] [Related]
14. Tetrandrine enhances cytotoxicity of cisplatin in human drug-resistant esophageal squamous carcinoma cells by inhibition of multidrug resistance-associated protein 1.
Wang TH; Wan JY; Gong X; Li HZ; Cheng Y
Oncol Rep; 2012 Nov; 28(5):1681-6. PubMed ID: 22941407
[TBL] [Abstract][Full Text] [Related]
15. Loss of periplakin expression is associated with the tumorigenesis of colorectal carcinoma.
Li X; Zhang G; Wang Y; Elgehama A; Sun Y; Li L; Gu Y; Guo W; Xu Q
Biomed Pharmacother; 2017 Mar; 87():366-374. PubMed ID: 28068625
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of DACH1 activity by short hairpin RNA represses cell proliferation and tumor invasion in pancreatic cancer.
Bu XN; Qiu C; Wang C; Jiang Z
Oncol Rep; 2016 Aug; 36(2):745-54. PubMed ID: 27278537
[TBL] [Abstract][Full Text] [Related]
17. Targeting TYRO3 inhibits epithelial-mesenchymal transition and increases drug sensitivity in colon cancer.
Chien CW; Hou PC; Wu HC; Chang YL; Lin SC; Lin SC; Lin BW; Lee JC; Chang YJ; Sun HS; Tsai SJ
Oncogene; 2016 Nov; 35(45):5872-5881. PubMed ID: 27132510
[TBL] [Abstract][Full Text] [Related]
18. MC70 potentiates doxorubicin efficacy in colon and breast cancer in vitro treatment.
Azzariti A; Quatrale AE; Porcelli L; Colabufo NA; Cantore M; Cassano G; Gasparre G; Iannelli G; Tommasi S; Panaro MA; Paradiso A
Eur J Pharmacol; 2011 Nov; 670(1):74-84. PubMed ID: 21925160
[TBL] [Abstract][Full Text] [Related]
19. Characterization of side population cells isolated from the colon cancer cell line SW480.
Xiong B; Ma L; Hu X; Zhang C; Cheng Y
Int J Oncol; 2014 Sep; 45(3):1175-83. PubMed ID: 24926880
[TBL] [Abstract][Full Text] [Related]
20. miR-378 suppresses the proliferation, migration and invasion of colon cancer cells by inhibiting SDAD1.
Zeng M; Zhu L; Li L; Kang C
Cell Mol Biol Lett; 2017; 22():12. PubMed ID: 28725241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
